Lloyd-Smith Malcolm has filed 5 insider transactions across 1 company since January 2023.
Most recent transaction: a sale of 801 shares of NEUROCRINE BIOSCIENCES INC ($NBIX) on February 06, 2023.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 6, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lloyd-Smith Malcolm | Chief Integration Officer | S | Common Stock | 801 | $105.82 | 29,300.0000 | 98,900,000 | 2.66% | 0.00% |
| Feb. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lloyd-Smith Malcolm | Chief Integration Officer | S | Common Stock | 1015 | $102.16 | 30,213.0000 | 98,900,000 | 3.25% | 0.00% |
| Feb. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lloyd-Smith Malcolm | Chief Integration Officer | S | Common Stock | 12801 | $102.41 | 41,710.0000 | 98,900,000 | 23.48% | 0.01% |
| Feb. 8, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lloyd-Smith Malcolm | Chief Integration Officer | S | Common Stock | 701 | $103.83 | 42,337.0000 | 98,900,000 | 1.63% | 0.00% |
| Jan. 31, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lloyd-Smith Malcolm | Chief Integration Officer | S | Common Stock | 1666 | $110.02 | 28,582.0000 | 98,900,000 | 5.51% | 0.00% |